menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Biologics' ×
Ray Huml
With patent expirations looming, biologic companies must innovate – or litigate – to protect their market share.
Read More
Brad Smith
Forrest Anthony
How Adoptive Cellular Therapy could change the standard of care for cancer patients around the world.
Read More
Ray Huml
Eric Groves
Five challenges of delivering immuno-oncology trials and how to overcome them.
Read More
John Doyle
Value frameworks could offer useful insight into the benefits of different treatments, but lack of consistency may limit their use.
Read More
Jaclyn Bosco
ISPOR workshop examines the post-approval biosimilar experience and the role real-world evidence plays in their success.
Read More
Costa Panagos
Today’s complex clinical trials need the support of a laboratory that can provide scientific, technological, and operational expertise to better meet the needs of patients, sites, and the sponsors they support.
Read More
AnandTharmaratnam
Biosimilars offer a huge opportunity in Asia to bring effective treatment options to a population desperate for cost-effective treatments.
Read More
Kimberly Robasky
If your employer is interested in identifying new biomarkers for oncology and immunology therapies, you should be investigating HLA-typing of new and legacy data. There is considerable insight to be gained from these exciting new research opportunities. Human Leukocyte Antigen (HLA) typing has long been a standard tool for tissue matching in transplant medicine, however the HLA region also has significant applications for oncology biomarkers, disease association and pharmacogenomics. And with the recent advent of next-generation sequencing technology and advances in statistical phasing, there are now multiple, cost-effective options to HLA-type individuals in addition to the current “gold standard” technology of “Sequence-Based Typing”, or SBT. Some of these innovations are also...
Read More